1-4 of 4
Cheng-Chung Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elevated plasma osteopontin associated with gastric cancer development, invasion and survival

Chun-Ying Wu, Ming-Shiang Wu, En-Pei Chiang, Cheng-Chung Wu, Yi-Ju Chen, Chien-Jen Chen, Nai-Hui Chi, Gran-Hum Chen, Jaw-Town Lin
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2686.
Published: 01 May 2007
View article
Journal Articles

PI-88, a novel heparanase inhibitor, as adjuvant therapy for hepatocellular carcinoma: A large randomized phase II clinical trial

Anand Gautam, Elizabeth Wilson, Pei-Jer Chen, Po-Huang Lee, Deng-Yn Lin, Cheng-Chung Wu, Long-Bin Jeng, Pin-Wen Lin, King-Tong Mok, Chun-Jen Liu, Wei-Chen Lee, Hong-Zen Yeh, Kuan-Lang Lai, Shi-Chung Chang
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2650.
Published: 01 May 2007
View article
Journal Articles

Hypomethylation of urokinase promoter as a prognostic marker in patients with gastric adenocarcinoma

EnPei Chiang, Chun-Yin Wu, Cheng-Chung Wu, Yin-Ting Shih, Shu-Wei Nein, Feng-Liang Tsai, Nai-Hui Chi
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1137.
Published: 01 May 2007
View article
Journal Articles

Cox-2 inhibitor, up-regulates CRMP1 expression through Sp1 and CEBPα

Shuenn-Chen Yang, Cheng-Chung Wu, Chiu-Wen Lin, Jeremy J.w
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 820–821.
Published: 15 April 2006
View article